Colchicum sanguicolle
Colchicum sanguicolle · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Colchicum sanguicolle is a distinctive plant species that has garnered significant scientific interest due to its unique chemical properties. Recent pharmacological studies have focused on the potential medicinal applications of this species, particularly regarding its biological activities. Researchers are specifically investigating the antitumor effects that may be derived from its complex molecular profile. To explore these therapeutic benefits, various laboratory preparations including plant extracts have been developed for testing. This ongoing research aims to uncover how these specialized compounds might combat various forms of cancer.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Colchicaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Taxonomy
Colchicum sanguicolle is a distinct species belonging to the vast kingdom Plantae. Within this botanical realm, it is classified under the class Equisetopsida. Its specific taxonomic lineage places it in the order Liliales, showcasing its evolutionary connections. Furthermore, the plant is a member of the family Colchicaceae, which defines many of its unique biological traits. Ultimately, this species is identified by its placement within the specialized genus Colchicum.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Liliales |
| Family | Colchicaceae |
| Genus | Colchicum |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Colchicum sanguicolle is a distinctive botanical species primarily found within the Asia-temperate region. Its natural range extends across the diverse landscapes of Western Asia, where it adapts to specific local climates. Within these territories, Türkiye serves as a significant area for its distribution and growth. Understanding its geographic footprint helps researchers better appreciate the ecological niches this plant occupies. Consequently, mapping its presence provides vital insights into the floral biodiversity of these ancient lands.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Colchicum sanguicolle is a self-supporting plant that maintains its own structural integrity without the need for external support.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Colchicum sanguicolle has demonstrated significant antitumor activity according to recent experimental research. By testing extracts of this endemic Turkish species on HeLa and C4-I cell lines, scientists identified its potential for cancer therapy. The study revealed that this plant was the most effective among those tested, showing high potency at very low concentrations. Specifically, the C4-I cervical cancer cells exhibited a high level of sensitivity to the extracts during the evaluation period. These promising results suggest that the species could play a vital role in the future design and development of new anticancer drugs.
Compounds
Conditions
Colchicum sanguicolle exhibits significant antitumor activity against both HeLa and C 4-I cervical cancer cell lines. In experimental studies, the extracts of this endemic Turkish plant proved to be the most effective among the varieties tested. Specifically, the extract demonstrated a potent effect on HeLa cells with an IC50 dose of 0.01 mg/ml after 48 hours of application. Furthermore, the treatment showed even greater efficacy against C 4-I cells, which reached an IC50 dose of 0.001 mg/ml during the same period. These findings indicate that C 4-I cells are particularly sensitive to the medicinal properties of Colchicum sanguicolle.
Preparations
Colchicum sanguicolle is prepared as extracts to investigate its potential antitumor activities against specific cancer cell lines. In this study, researchers utilized various doses of these extracts to test their effects on HeLa and C 4-I cells. The prepared Colchicum sanguicolle extracts demonstrated the most significant antitumor activity compared to other plant types tested. Specifically, the extracts showed high efficacy with IC50 values of 0.01 mg/ml for HeLa cells and 0.001 mg/ml for C 4-I cells at the 48-hour mark. These results highlight the importance of utilizing Colchicum sanguicolle extracts in the ongoing development of new anticancer drugs.